Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
225 participants
OBSERVATIONAL
2021-10-01
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Radiomics Study for Breast Cancer
NCT06095414
MR Characterisation/Localisation of Breast Cancer
NCT01567137
Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy
NCT01257152
The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
NCT06370234
Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer
NCT04656639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
MRI based classification of breast cancer histological factors and subtypes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
27 Years
86 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University Ansan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bo Kyoung Seo
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bo Kyoung Seo, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Korea University Ansan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bo Kyoung Seo
Ansan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jeong J, Ham S, Seo BK, Lee JT, Wang S, Bae MS, Cho KR, Woo OH, Song SE, Choi H. Superior performance in classification of breast cancer molecular subtype and histological factors by radiomics based on ultrafast MRI over standard MRI: evidence from a prospective study. Radiol Med. 2025 Mar;130(3):368-380. doi: 10.1007/s11547-025-01956-6. Epub 2025 Jan 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFMRIRADIOMICS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.